English - onset.to

January 3, 2027

UK petition calls for a legal review of psilocybin access and policy, asking Parliament to consider reform for medical use, research, and reduced criminal penalties

petition.parliament.uk · Jan 3, 2027

Psilocybin Mainstream Policy Research

November 26, 2026

How to Hold a Cockroach: A Philosophical Invitation to Question Fear, Identity, Love, and the Truths We Hold

penguin.co.uk · Nov 26, 2026 · Matthew Maxwell

Article Consciousness Philosophy Spirituality

November 5, 2026

Waves and Stones: Graham Harman explores how continuity and sudden change shape reality, science, history, and human life

penguin.co.uk · Nov 5, 2026 · Graham Harman

Article Consciousness Philosophy Research

October 3, 2026

Federal judge calls Flock search unconstitutional as lawmakers introduce a bill to ban license plate readers

techspot.com · Oct 3, 2026 · Daniel Sims

Article Policy Society Technology

October 2, 2026

Is HHS too cosy with the psychedelic industry, and is the public being misled about psychedelic risks?

ecstaticintegration.org · Oct 2, 2026 · Jules Evans

LSD Psilocybin Article Industry +2

October 1, 2026

Stoicism Is Not What You Think: John Sellars Challenges Myths About an Ancient Philosophy for Modern Life

penguin.co.uk · Oct 1, 2026 · John Sellars

Article Culture Education Philosophy

September 29, 2026

MAPS opposes the DEA's attempt to place five lesser-known tryptamines into Schedule I under the Controlled Substances Act

maps.org · Sep 29, 2026 · Ismail L. Ali, J.D.

Article Policy Research Safety

September 28, 2026

Psychedelics reduce bottom-up brain activity in the default mode network across humans and mice

psypost.org · Sep 28, 2026 · Karina Petrova

LSD Psilocybin Article Clinical +2

September 27, 2026

Exploratory clinical trial finds ayahuasca combined with meaning reconstruction therapy may ease severe bereavement

psypost.org · Sep 27, 2026 · Karina Petrova

Ayahuasca Article Clinical Research Therapy

September 25, 2026

Scientists identify the LSD structural elements that trigger hallucinations and create a promising non-hallucinogenic antipsychotic analogue

psypost.org · Sep 25, 2026 · Eric W. Dolan

LSD Article Clinical Research Safety

Clay Martin, psilocybin, and the Path of the Barbarian Spirit: A veteran’s violent pagan psychedelic church

ecstaticintegration.org · Sep 25, 2026 · Jules Evans

Psilocybin Article Community Culture Spirituality

September 24, 2026

Psychedelic Churches and the Expanding Legal Landscape of Religious Exemptions Amid Commercialization and Regulatory Scrutiny

yalejreg.com · Sep 24, 2026 · Elizabeth Sepper

Psilocybin Ayahuasca Article Ethics +2

Draulio Araújo on the path from ayahuasca research to controlled DMT trials for treatment-resistant depression

behavioralwire.com · Sep 24, 2026 · Editorial Desk

DMT Ayahuasca Article Clinical +2

Psilocybin durably increases sociability in an autism mouse model even when administered under anesthesia

psypost.org · Sep 24, 2026 · Eric W. Dolan

Psilocybin Article Clinical Research Safety

A Single Supported Psilocybin Session Was Linked to Months of Reduced Cancer-Related Anxiety and Depression

mindbodygreen.com · Sep 24, 2026

Psilocybin Article Clinical Research Therapy

September 23, 2026

First fMRI study of mescaline in awake rats finds reduced cerebellar activity, increased brain connectivity, and frequency-specific sensory filtering

psypost.org · Sep 23, 2026 · Bianca Setionago

Mescaline Article Consciousness Research Safety

A Phase 1 trial tests psilocybin for borderline personality disorder while keeping dialectical behavior therapy in place

behavioralwire.com · Sep 23, 2026 · Editorial Desk

Psilocybin Article Clinical Research Safety

DEA proposes Schedule I classification for five synthetic tryptamine psychedelics, threatening research and clinical development

mindmedicinelaw.com · Sep 23, 2026 · The Psychedelic Journal

Article Policy Research Safety

DEA renews effort to place five psychedelic tryptamines in Schedule I as FDA research progress draws criticism from advocates

psychedelicamericas.org · Sep 23, 2026 · PSA Media Team, Jack Gorsline

Article Industry Policy Research

September 22, 2026

Psilocybin may help the brain recover from repeated concussion, but evidence remains limited to animal research

theconversation.com · Sep 22, 2026 · Argel Aguilar Valles

Psilocybin Article Clinical Research Safety

FDA hearing, VA psychedelic bill claims, and Alabama's marijuana rescheduling objection shape September 2026 policy briefing

psychedelicstoday.com · Sep 22, 2026 · Jack Gorsline

Psilocybin MDMA Article Industry +2

After an Ayahuasca Retreat: Research-Based Answers to Questions About Integration, Difficulties, Grounding, Community and Help

hummingbirdhealingcenter.org · Sep 22, 2026 · Jim Davis

Psilocybin Ayahuasca Article Integration +2

Psychedelic realism with Danny Forde: phenomenology, mystical experience, ego dissolution, and the search for truth

divergentstates.buzzsprout.com · Sep 22, 2026

Podcast Consciousness Philosophy Research

September 21, 2026

Podcast: Psychedelics in D.C., FDA’s Framework, and New Zealand’s MDMA Prescribers

psychedelicalpha.com · Sep 21, 2026 · Josh Hardman

Ibogaine MDMA Podcast Industry +2

Cybin CEO Michael Halstead reports purchasing 100,000 common shares at a weighted average price of $13.4705

ir.helus.com · Sep 21, 2026 · Michael Halstead

Article Business Industry